Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma

This study has been completed.
Information provided by:
Sanofi Identifier:
First received: February 26, 2008
Last updated: October 1, 2009
Last verified: October 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2004
  Primary Completion Date: June 2004 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):